| Product ID |
Product Name |
CAS# |
Purity |
| D762717 |
[4-(tert-Butyldimethylsilyloxymethyl)cyclohexyl]methanol |
141836-50-2 |
97% |
| D770454 |
CyclopentanepropanaMide, a-aMino-N-cyclopropyl-, hydrochloride (1 |
1404457-08-4 |
96% |
| Y1251360 |
dibenzyl 1-(4-(Methoxycarbonyl)benzyl)-2-Methylhydrazine-1,2-dicarboxylate |
1369503-21-8 |
98% |
| Y1238343 |
EPZ004777 HCl |
1380316-03-9 |
98% |
| D762195 |
ethyl 2-(2-ethoxy-2-oxoethyl)-4-nitrobenzoate |
1253790-99-6 |
98% |
| D762335 |
ethyl 3-(2-ethoxypyriMidin-5-yl)propanoate |
1314534-00-3 |
98% |
| D770455 |
ethyl 4-(1-hydrazinylethyl)benzoate benzenesulfonate |
1415565-11-5 |
98% |
| Y1238312 |
GSK-525768A |
1260530-25-3 |
99% |
| Y1242799 |
GSK-256066 (2,2,2-trifluoroacetic acid) |
1415560-64-3 |
99% |
| Y1242800 |
HG6-64-1 |
1315329-43-1 |
95% |
| Y1238254 |
JW 642 |
1416133-89-5 |
98% |
| Y1238255 |
LEE011 (succinate hydrate) |
1374639-79-8 |
99% |
| D770456 |
L-Proline, 4-[(3-chloro-7-Methoxy-2-quinoxalinyl)oxy]-, Methyl ester, (hydrochloride)(1 |
1361028-94-5 |
98% |
| Y3105873 |
Methyl 1-(4-broMophenyl)-3-oxocyclobutanecarboxylate |
1364663-42-2 |
98% |
| D770458 |
Methyl 2-(4-hydroxy-1-Methylpiperidin-4-yl)acetate |
1415564-49-6 |
98+% |
| D962922 |
Methyl 4-fluoro-1-Methyl-5-(phenylaMino)-1H-benzo[d]iMidazole-6-carboxylate |
1415564-48-5 |
98% |
| D762559 |
Methyl 4-hydroxy-5-Methoxy-1-Methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate |
1354639-61-4 |
97% |
| Y1247203 |
MK-8033 (hydrochloride) |
1283000-43-0 |
98% |
| D762167 |
N1-(4-Methoxybenzyl)-N7,N7-diMethyl-3-M-tolylisoquinoline-1,7-diaMine |
1248622-41-4 |
98% |
| Y1242871 |
N-desMethyl EnzalutaMide |
1242137-16-1 |
99% |
| D770459 |
N-propyl-4,5,6,7-tetrahydrobenzo[d]thiazol-6-aMine (Hydrochloride) |
1415559-98-6 |
96% |
| Y1247236 |
NVP-BKM120 (Hydrochloride) |
1312445-63-8 |
99% |
| D762124 |
Phosphine oxide, [(2R)-2,3-diMethyl-3-[(triethylsilyl)oxy]butyl]diphenyl- |
1227926-70-6 |
97% |
| D762712 |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 2,6-dibroMo-8-cyclopentyl-5-Methyl- |
1415560-29-0 |
97% |
| D958562 |
4,6-dichloro-2-(propylthio)pyriMidine |
1401318-10-2 |
95% |
| Y1251575 |
ST-836 hydrochloride |
1415564-68-9 |
98% |
| Y1054551 |
tert-butyl (3aR,4S,6aS)-octahydrocyclopenta[c]pyrrol-4-ylcarbaMate coMpound with tert-butyl (3aS,4R,6aR)-octahydrocyclopenta[c]pyrrol-4-ylcarbaMate (1 |
1228030-08-7 |
95% |
| D762288 |
tert-butyl 2-((5-chlorobenzo[d]oxazol-2-yl)(3-oxobutyl)aMino)ethylcarbaMate |
1276666-10-4 |
98% |
| D762341 |
tert-butyl 5,6,7,8-tetrahydroquinolin-8-ylcarbaMate |
1313712-47-8 |
97% |
| D762665 |
Uridine, 4'-C-azido-5'-deoxy-5'-iodo-, 2',3'-dibenzoate |
139419-02-6 |
95+% |
| D749623 |
5'-deoxy-5'-iodouridine |
14259-58-6 |
97% |
| Y1054684 |
VcMMAD |
1401963-17-4 |
97% |
| Y1251576 |
VT-464 (R enantioMer) |
1375603-38-5 |
99% |
| D770462 |
R)-2-(2-tert-butoxy-2-oxoethyl)-5,5,5-trifluoropentanoic acid |
1401067-08-0 |
98% |
| D770464 |
(R)-1-phenylethanamine (S)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate |
1394138-46-5 |
97% |
| Y1251522 |
(S)-(-)-5-Fluorowillardiine (hydrochloride) |
1321546-70-6 |
98% |
| Y3130835 |
3-Bromo-4-chloro-2-methylquinoline |
1333256-98-6 |
95% |
| D770466 |
3-Pyridinecarbonitrile, 1,2-dihydro-4-methoxy-6-methyl-2-oxo- |
1354528-16-7 |
95+% |
| D964215 |
3-Quinolineacetic acid, 4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-a-(1,1-dimethylethoxy)-2-methyl-, methyl ester, (aS,4R)- |
1402714-51-5 |
98% |
| D770467 |
3-Quinolineacetic acid,4-chloro-a-hydroxy-2-methyl-, methyl ester, (aS)- |
1402597-30-1 |
95+% |
| Y3131054 |
Alimemazine D6 |
1346603-88-0 |
99% |
| Y1247245 |
Aliskiren-d6 Hydrochloride |
1246815-96-2 |
99%D |
| Y1247277 |
AMpkinone |
1233082-79-5 |
99% |
| Y1251577 |
Azilsartan-d5 |
1346599-45-8 |
98% |
| Y3305601 |
BUPROPION MORPHOLINOL-D6 |
1216893-18-3 |
98.15% |
| Y1247191 |
Ca2+ channel agonist 1 |
1402821-24-2 |
99% |
| Y3106385 |
CANDESARTAN-D4 |
1346604-70-3 |
98% |
| D770471 |
Carbamic acid, N-[[4-[(hydroxyimino)methyl]phenyl]methyl]-N-methyl-, 1,1-dimethylethyl ester |
1349198-30-6 |
98% |
| Y1247193 |
6H-PyriMido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-Methoxy-4-(4-Methyl-1-piperazinyl)phenyl]aMino]-5,11-diMethyl- |
1234479-76-5 |
98% |
| Y3297998 |
Febuxostat-d9 |
1246819-50-0 |
95% |
| Y3288196 |
GDC 0068 (Hydrochloride) |
1396257-94-5 |
99% |
| Y3141224 |
GDC-0339 |
1428569-85-0 |
99% |
| Y1247194 |
IDO-IN-5 |
1402837-79-9 |
95% |
| Y1247227 |
IDO-IN-6 |
1402837-76-6 |
99% |
| Y3140949 |
IDO-IN-8 |
1402837-77-7 |
95% |
| Y1247228 |
N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-1H-pyrazol-3-yl)propanamide |
1333146-24-9 |
98% |
| Y1251629 |
Losartan-d4 Carboxylic Acid |
1246820-62-1 |
98%:d4 |
| D770474 |
(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-cyano-2,6-dimethylphenyl)propanoate |
1227311-10-5 |
95+% |
| Y1343837 |
2-[[3-(4-Morpholinyl)propyl]amino]-4-pyridinecarboxylic acid 2-[1-(4-chloro-2-hydroxyphenyl)propylidene]hydrazide |
1395048-49-3 |
98% |
| Y1255929 |
MANGAFODIPIR TRISODIUM F0D2720.996MG/MG(AN) |
140678-14-4 |
99% |
| Y1251508 |
MEFEXAMIDE HYDROCHLORIDE |
1227-61-8 |
98% |
| Y1256037 |
Nav1.7-IN-2 |
1332295-35-8 |
99% |
| Y1255908 |
Nepafenac-D5 |
1246814-53-8 |
98% |
| Y3141448 |
Nitazoxanide-d4 |
1246819-17-9 |
95% |
| Y3106520 |
Olmesartan-d4 |
1420880-41-6 |
98% |
| D964331 |
Pyrrolo[3,4-c]pyrazole-5(1H)-carboxylic acid, 3a,4,6,6a-tetrahydro-6a-hydroxy-, 1,1-dimethylethyl ester |
1211594-55-6 |
97% |
| Y3309399 |
QUETIAPINE-D8 FUMARATE |
1287376-15-1 |
99% |
| Y3140738 |
ROSUVASTATIN-D3 |
1279031-70-7 |
95% |
| Y1260364 |
USP7-IN-1 |
1381291-36-6 |
98% |
| Y1260375 |
VBY-825 |
1310340-58-9 |
99% |
| Y1260365 |
YHO-13351 |
1346753-00-1 |
98% |
| Y1255911 |
2-Pyrazinecarbonitrile, 5-[[5-(2-hydroxy-6-methoxyphenyl)-1H-pyrazol-3-yl]amino]-, dihydrochloride |
1234015-70-3 |
97% |
| Y1256045 |
A-1155463 |
1235034-55-5 |
95% |
| Y1260377 |
CC-115 (hydrochloride) |
1300118-55-1 |
98% |
| Y1256038 |
S-(E-1,2-DICHLOROVINYL)-L-CYSTEINE |
13419-46-0 |
99% |
| Y3109954 |
(R)-2-(1-(tert-butoxycarbonyl)pyrrolidin-3-yl)Malonic acid |
1228312-13-7 |
98% |
| Y1264684 |
(S)-(4-(1-AMINOETHYL)PHENYL)METHANOL |
1213446-52-6 |
95% |
| Y3141217 |
5-(tert-butyldiMethylsilanyloxyMethyl)-5-phenyliMidazolidine-2,4-dione |
1401226-49-0 |
95% |
| D770480 |
5-bromo-2-ethoxyisonicotinic acid |
1379305-67-5 |
98% |
| Y3245233 |
Lorcaserin hydrochloride |
1431697-94-7 |
98% |
| Y1343767 |
Acetylene-linker-Val-Cit-PABC-MMAE |
1411977-95-1 |
95% |
| Y1256042 |
BET-IN-1 |
1422554-34-4 |
99% |
| Y3131556 |
Duvelisib (R enantiomer) |
1261590-48-0 |
95% |
| D770481 |
Ethanone,1-[4-(trifluoromethoxy)phenyl]-,oxime,(1E)- |
1265612-59-6 |
97% |
| Y3131746 |
(2-bromo-pyridin-4-yl)-acetic acid ethyl ester |
1256337-24-2 |
95% |
| Y3140829 |
1H-Azepine, 2,3,6,7-tetrahydro-, hydrochloride (1 |
1263282-12-7 |
95% |
| D964844 |
2(1H)-Isoquinolinecarboxylic acid, 8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-, 1,1-dimethylethyl ester |
1235034-71-5 |
97% |
| Y1238309 |
DiMethyl 1-benzoyl-5-oxopiperidin-2,4-dicarboxylate |
1255663-98-9 |
95% |
| Y1238284 |
CH3SO3H |
1236208-20-0 |
97% |
| Y1242757 |
Lp-PLA2 -IN-1 |
1420367-28-7 |
99% |
| Y1238263 |
OTSSP167HCL |
1431698-10-0 |
99% |
| Y1238204 |
PI4KIIIbeta-IN-9 |
1429624-84-9 |
99% |
| Y3287199 |
RSL3 |
1219810-16-8 |
98% |
| Y1238341 |
TCV-309 (chloride) |
121494-09-5 |
98% |
| D770484 |
Toluene-4-sulfonic acid cis-3-benzyloxycyclobutyl ester |
1262278-62-5 |
97% |
| Y1054722 |
Tosufloxacin p-Toluenesulfonate Hydrate |
1400591-39-0 |
98% |
| Y1242760 |
4-broMo-2-phenylthiazole |
141305-40-0 |
97% |
| Y1339710 |
(S)-2-(tert-butoxycarbonylaMino)-2-(3-fluorophenyl)acetic acid |
1228542-64-0 |
97% |
| Y1080320 |
(E)-1,7-BIS(4-HYDROXY-3-METHOXYPHENYL)HEPT-4-EN-3-ONE |
128700-97-0 |
98% |
| Y1238336 |
tert-Butyl 4-(6-forMylpyrazolo[1,5-a]pyriMidin-2-yl)piperidin-1-carboxylate |
1258638-43-5 |
95% |